Focusing on ferroptosis in alveolar bone loss during periodontitis: From mechanisms to therapies
International Immunopharmacology · 2025-05 · 156 · 114683
DOI: 10.1016/j.intimp.2025.114683 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Immunopharmacology, 2025-05. Verfasst von Yuting Tang und 3 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Oral Diseases, National Clinical Research Center for Oral Diseases, West China School of Stomatology, Sichuan University, Che…. Hauptthemen laut MEDLINE: Ferroptosis, Periodontitis, Alveolar Bone Loss. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 109 Literaturangaben. Gefördert von: Applied Basic Research Program of Sichuan Province.
Abstract (Originalsprache)
Periodontitis is an oral immunoinflammatory disease induced by bacterial infection. During periodontitis, the aggravating destruction of the alveolar bone can result in tooth movement and even tooth loss. Current conventional treatments for periodontitis primarily focus on infection control, but their effectiveness in halting and restoring alveolar bone destruction is limited. To identify additional therapeutic targets, researchers have been dedicated to investigating other pathological mechanisms underlying alveolar bone loss during periodontitis. Recently, findings indicate that ferroptosis plays a role in the development of periodontitis. Ferroptosis is a nonapoptotic type of cell death marked by iron accumulation and lipid peroxidation. Recent investigations have revealed the complex interplay of ferroptosis and inflammation. The positive feedback loop between ferroptosis and inflammation may significantly contribute to the exacerbation of alveolar bone loss. In light of the advancements in research within this field in recent years, this review intends to thoroughly summarize the processes by which ferroptosis aggravates alveolar bone loss during periodontitis, along with relevant ferroptosis-targeted therapeutic agents. By highlighting the latest advancements in this area, we hope this review will inspire researchers to develop novel therapeutic strategies for more effective inflammation control and regeneration of alveolar bone.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- State Key Laboratory of Oral Diseases, National Clinical Research Center for Oral Diseases, West China School of Stomatology, Sichuan University, Chengdu 610041, China.
- State Key Laboratory of Oral Diseases, National Clinical Research Center for Oral Diseases, West China School of Stomatology, Sichuan University, Chengdu 610041, China; Department of General Dentistry, West China School…
Förderung
- Applied Basic Research Program of Sichuan Province
Zitieren
APA
Tang, Y., Leng, J., Luo, Y., & Luo, F. (2025). Focusing on ferroptosis in alveolar bone loss during periodontitis: From mechanisms to therapies. International Immunopharmacology, 156, 114683. https://doi.org/10.1016/j.intimp.2025.114683
Vancouver
Tang Y, Leng J, Luo Y, Luo F. Focusing on ferroptosis in alveolar bone loss during periodontitis: From mechanisms to therapies. International Immunopharmacology. 2025;156:114683. doi:10.1016/j.intimp.2025.114683
BibTeX
@article{Tang2025,
author = {Tang, Yuting and Leng, Junyan and Luo, Yankun and Luo, Feng},
title = {Focusing on ferroptosis in alveolar bone loss during periodontitis: From mechanisms to therapies},
journal = {International Immunopharmacology},
year = {2025},
volume = {156},
pages = {114683},
doi = {10.1016/j.intimp.2025.114683}
}
EUVIMED